These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10466627)

  • 41. Bone marrow stem cell gene therapy of arylsulfatase A-deficient mice, using an arylsulfatase A mutant that is hypersecreted from retrovirally transduced donor-type cells.
    Matzner U; Schestag F; Hartmann D; Lüllmann-Rauch R; D'Hooge R; De Deyn PP; Gieselmann V
    Hum Gene Ther; 2001 Jun; 12(9):1021-33. PubMed ID: 11399225
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Partial correction of the alpha-galactosidase A deficiency and reduction of glycolipid storage in Fabry mice using synthetic vectors.
    Przybylska M; Wu IH; Zhao H; Ziegler RJ; Tousignant JD; Desnick RJ; Scheule RK; Cheng SH; Yew NS
    J Gene Med; 2004 Jan; 6(1):85-92. PubMed ID: 14716680
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Correction of the biochemical and functional deficits in fabry mice following AAV8-mediated hepatic expression of alpha-galactosidase A.
    Ziegler RJ; Cherry M; Barbon CM; Li C; Bercury SD; Armentano D; Desnick RJ; Cheng SH
    Mol Ther; 2007 Mar; 15(3):492-500. PubMed ID: 17191071
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gene transfer and expression of human alpha-galactosidase from mouse muscle in vitro and in vivo.
    Novo FJ; Górecki DC; Goldspink G; MacDermot KD
    Gene Ther; 1997 May; 4(5):488-92. PubMed ID: 9274727
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Retrovirus-mediated expression of the base excision repair proteins, formamidopyrimidine DNA glycosylase or human oxoguanine DNA glycosylase, protects hematopoietic cells from N,N',N"-triethylenethiophosphoramide (thioTEPA)-induced toxicity in vitro and in vivo.
    Kobune M; Xu Y; Baum C; Kelley MR; Williams DA
    Cancer Res; 2001 Jul; 61(13):5116-25. PubMed ID: 11431349
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Gene therapy of Gaucher's and Fabry's diseases: current status and prospects].
    Fabrega S; Lehn P
    J Soc Biol; 2002; 196(2):175-81. PubMed ID: 12360746
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 4-Phenylbutyrate rescues trafficking incompetent mutant alpha-galactosidase A without restoring its functionality.
    Yam GH; Roth J; Zuber C
    Biochem Biophys Res Commun; 2007 Aug; 360(2):375-80. PubMed ID: 17592721
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Local ex vivo gene therapy with bone marrow stromal cells expressing human BMP4 promotes endosteal bone formation in mice.
    Zhang XS; Linkhart TA; Chen ST; Peng H; Wergedal JE; Guttierez GG; Sheng MH; Lau KH; Baylink DJ
    J Gene Med; 2004 Jan; 6(1):4-15. PubMed ID: 14716672
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Toward gene therapy for Gaucher disease.
    Kohn DB; Nolta JA; Weinthal J; Bahner I; Yu XJ; Lilley J; Crooks GM
    Hum Gene Ther; 1991; 2(2):101-5. PubMed ID: 1911928
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Retroviral-mediated transfer of the murine interleukin-3 gene engineered for intracellular retention results in a myeloproliferative syndrome but is associated with circulating interleukin-3 levels.
    Orchard PJ; Detrick RA; Gorden K; Dunbar CE; Vallera DA; Taylor P; McIvor RS; Blazar BR
    Exp Hematol; 1993 Aug; 21(9):1245-54. PubMed ID: 8330649
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Purification and characterization of human alpha-galactosidase A expressed in insect cells using a baculovirus vector.
    Chen Y; Jin M; Goodrich L; Smith G; Coppola G; Calhoun DH
    Protein Expr Purif; 2000 Nov; 20(2):228-36. PubMed ID: 11049747
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reduced alpha-Gal A enzyme activity in Fabry fibroblast cells and Fabry mice tissues induced by serum from antibody positive patients with Fabry disease.
    Ohashi T; Iizuka S; Ida H; Eto Y
    Mol Genet Metab; 2008 Jul; 94(3):313-8. PubMed ID: 18456533
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rapid Clathrin-Mediated Uptake of Recombinant α-Gal-A to Lysosome Activates Autophagy.
    Ivanova MM; Dao J; Kasaci N; Adewale B; Fikry J; Goker-Alpan O
    Biomolecules; 2020 May; 10(6):. PubMed ID: 32486191
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Engraftment of gene-marked hematopoietic progenitors in myeloma patients after transplant of autologous long-term marrow cultures.
    Stewart AK; Sutherland DR; Nanji S; Zhao Y; Lutzko C; Nayar R; Peck B; Ruedy C; McGarrity G; Tisdale J; Dubé ID
    Hum Gene Ther; 1999 Aug; 10(12):1953-64. PubMed ID: 10466629
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gene transfer to human rheumatoid synovial tissue engrafted in SCID mice.
    Jorgensen C; Demoly P; Noel D; Mathieu M; Piechaczyc M; Gougat C; Bousquet J; Sany J
    J Rheumatol; 1997 Nov; 24(11):2076-9. PubMed ID: 9375863
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vivo methotrexate selection of murine hemopoietic cells transduced with a retroviral vector for Gaucher disease.
    Havenga M; Valerio D; Hoogerbrugge P; Es H
    Gene Ther; 1999 Oct; 6(10):1661-9. PubMed ID: 10516714
    [TBL] [Abstract][Full Text] [Related]  

  • 57. alpha-Galactosidase A deficient mice: a model of Fabry disease.
    Ohshima T; Murray GJ; Swaim WD; Longenecker G; Quirk JM; Cardarelli CO; Sugimoto Y; Pastan I; Gottesman MM; Brady RO; Kulkarni AB
    Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2540-4. PubMed ID: 9122231
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Distribution of alpha-galactosidase A in normal human kidney and renal accumulation and distribution of recombinant alpha-galactosidase A in Fabry mice.
    Christensen EI; Zhou Q; Sørensen SS; Rasmussen AK; Jacobsen C; Feldt-Rasmussen U; Nielsen R
    J Am Soc Nephrol; 2007 Mar; 18(3):698-706. PubMed ID: 17287429
    [TBL] [Abstract][Full Text] [Related]  

  • 59. AAV2 vector harboring a liver-restricted promoter facilitates sustained expression of therapeutic levels of alpha-galactosidase A and the induction of immune tolerance in Fabry mice.
    Ziegler RJ; Lonning SM; Armentano D; Li C; Souza DW; Cherry M; Ford C; Barbon CM; Desnick RJ; Gao G; Wilson JM; Peluso R; Godwin S; Carter BJ; Gregory RJ; Wadsworth SC; Cheng SH
    Mol Ther; 2004 Feb; 9(2):231-40. PubMed ID: 14759807
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Fabry's disease (alpha-galactosidase-A deficiency): recent therapeutic innovations].
    Germain DP
    J Soc Biol; 2002; 196(2):183-90. PubMed ID: 12360747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.